Phagos
Bacteriophage therapies for antibiotic-resistant infections.
Phagos harnesses bacteriophage evolution to develop targeted therapies for antibiotic-resistant infections. Its rapid discovery process enables new phage treatments in weeks, supporting personalized care against hard-to-treat bacteria.
Founders
Alexandros Pantalis
CEO
Alexandros holds a Master’s degree in Management from HEC Paris. He cofounded 4 tech startups and previously worked at EY.
Adèle James
CTO
Adèle holds a PhD in Molecular Microbiology from Sorbonne University. She’s one of 20 world experts in phage therapy applied to aquatic organisms and a L’Oréal-UNESCO fellow.